Sunday, June 21, 2015 10:13:06 AM
Chlormet closes acquisition of 9.7 acres in Washington
2015-06-09 09:38 ET - News Release
Mr. Yari Nieken reports
CHLORMET COMPLETES PURCHASE OF WASHINGTON STATE PROPERTY
Chlormet Technologies Inc. has completed the purchase of property located near Ferndale, Whatcom county, Washington state (see news releases dated Nov. 4, 2014, and May 28, 2015), and is now the registered owner by way of its subsidiary PacCan Industries LLC.
The property is 9.7 acres in size and has multiple buildings located on it. The largest building is approximately 13,000 square feet (of total floor space) and is divided into eight bays. Three separate tenants currently occupy six bays. Two tenants, who rent four bays between them, have been given notice to vacate by June 30, 2015. The company intends to meet with the third tenant with the goal of trying to sign a long-term lease.
The property is large enough for the construction of multiple additional large-scale buildings, and the company has engaged a developer to provide schematics and zoning guidance. During the escrow phase, the company had the property rezoned to reflect the recommendations of the developer.
The purchase price of the property was $1.2-million (U.S.), and the company has secured a third party mortgage on the property in the amount of $1.08-million (U.S.). The mortgage is non-recourse and has a 24-month term with 5-per-cent interest-only payments due monthly.
The company intends to generate revenue from the property via long-term rentals and/or leases for the building (or portions thereof). To further clarify, Chlormet will rely upon landlord exemption provisions under Washington State regulations RCW 69.50 and WAC 314-55 that allow for the lease of facilities, security equipment, fixtures, tenant improvements, utility services and maintenance/security services to state-licensed producers and processors.
The rents will be reasonable and fixed, and the company will not be involved in or participate in the business of its tenants.
"The company is thrilled to have closed a transaction that will in short order diversify its income. I was very pleased with the efforts put forth by both management and our consultants during the due diligence and rezoning processes," stated chief executive officer Yari Nieken.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM